SYMBIOTEC PHARMALAB LTD (SYMBIOTEC): SYMBIOTEC PHARMALAB Share Price hits fresh 52-week high at Rs 1,163.35

SYMBIOTEC Share Price was at Rs 1,163.35, up 2.55% from the previous close, after touching a fresh 52-week high of Rs 1,193.90 in early trade. The company’s market capitalisation stood at Rs 7,030.58 crore as of 10 September 2026 at 10:22 AM IST. The move places SYMBIOTEC Share Price news firmly in focus for readers tracking SYMBIOTEC Share Price Today, with the latest Univest data confirming the price event and the day’s range without establishing a company-specific catalyst.

For investors searching for SYMBIOTEC Share Price, the key point is straightforward: the stock is trading above its previous close of Rs 1,134.40 and has already printed a fresh one-year high in the current market update. The latest Univest figures also show turnover of Rs 12.28 crore, which provides a factual context for the day’s trading value. At this stage, the latest Univest figures explain what happened; they do not establish why the share moved.

SYMBIOTEC Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,163.35
Previous Close	Rs 1,134.4
Today's Move	+Rs 28.95 (+2.55%)
Open	Rs 1,136.1
High	Rs 1,193.9
Low	Rs 1,115
Turnover	Rs 12.28 crore
Market Capitalisation	Rs 7,030.58 crore

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) traded at Rs 1,163.35 versus the previous close of Rs 1,134.4, a rise of 2.55%. The stock opened at Rs 1,136.1, reached a high of Rs 1,193.9 and touched a low of Rs 1,115.

SYMBIOTEC Share Price Today shows a clear intraday move relative to the previous close. The stock opened at Rs 1,136.10, moved between Rs 1,115.00 and Rs 1,193.90, and last traded at Rs 1,163.35. The day change of Rs 28.95 and 2.55% places the stock above the prior close, while the fresh 52-week high of Rs 1,193.90 marks the highest level reached so far in this cycle. Turnover stood at Rs 12.28 crore, which adds a factual measure of trading value to the day’s share price update.

From a news perspective, SYMBIOTEC Stock News is being driven by the verified price event itself. The latest Univest data confirms the stock has moved into a new yearly high zone, and the relevant comparison is the previous 52-week high of Rs 1,193.90, which was matched during the move. That makes SYMBIOTEC Share Price live relevant for traders, trackers and long-term followers alike, while still leaving the cause of the move unconfirmed.

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 7,030.58 crore
P/E Ratio	66.32x
P/B Ratio	4.91x
ROE	11.22%
ROCE	12.41%
EPS	Rs 17.1
Book Value Per Share	Rs 231.19
Dividend Yield	0%

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) fundamental metrics show P/E 66.32x, P/B 4.91x, ROE 11.22%, ROCE 12.41%. These figures provide context only and are not a buy or sell signal.

SYMBIOTEC PHARMALAB LTD has a market capitalisation of Rs 7030.58 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 66.32x, P/B at 4.91x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.22% and ROCE of 12.41%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 17.1, book value per share of Rs 231.19, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.74x, median ROE of 11.87%, median ROCE of 13.88%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	66.32x
Benchmark Median P/E	32.74x
Benchmark Average P/E	48.99x
Benchmark P/E Range	3.4x to 706.55x
Company P/B Ratio	4.91x
Benchmark Median P/B	2.99x
Company ROE	11.22%
Benchmark Median ROE	11.87%
Company ROCE	12.41%
Benchmark Median ROCE	13.88%
Company Market Capitalisation	Rs 7,030.58 crore
Benchmark Median Market Cap	Rs 729.92 crore

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a P/E ratio of 66.32x, which is above the benchmark median of 32.74x, a difference of +102.57%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a ROE of 11.22%, which is below the benchmark median of 11.87%, a difference of -5.48%. SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a ROCE of 12.41%, which is below the benchmark median of 13.88%, a difference of -10.59%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
SENORES PHARMACEUTICALS L	SENORES	6,957.55	54.26	7.11	14.14	15.66
Sanofi India Ltd.	SANOFI	7,176.69	22.08	8.66	44.5	55.46
Supriya Lifescience Ltd.	SUPRIYA	7,334.4	36.97	6	19.06	25.3
Innova Captab Ltd.	INNOVACAP	6,711.34	43.66	6.01	13.75	15.04
Bliss GVS Pharma Ltd.	BLISSGVS	7,711.09	54.08	5.97	12.11	17.4

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a P/E ratio of 66.32x compared with the displayed peer median of 43.66x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.22% compares with a peer median of 14.14% across the companies shown in the table. ROCE stood at 12.41% versus the displayed peer median of 17.4%, providing a capital-efficiency comparison. SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a market capitalisation of Rs 7,030.58 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching SYMBIOTEC

• SYMBIOTEC Share Price touched a fresh 52-week high of Rs 1,193.90.
• The stock was last traded at Rs 1,163.35, up 2.55% from the previous close.
• Market capitalisation stood at Rs 7,030.58 crore in the latest Univest data.
• P/E of 66.32 is above the same-industry median of 32.74.
• ROE of 11.22% and ROCE of 12.41% provide a profitability context for SYMBIOTEC Share Price news.

About SYMBIOTEC PHARMALAB LTD

SYMBIOTEC PHARMALAB LTD operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. That classification places SYMBIOTEC Share Price within a large listed universe where valuation, profitability and market cap are often compared with other pharmaceutical names. For readers following SYMBIOTEC Company News, the stock’s fresh 52-week high adds a market event to that company profile.

SYMBIOTEC Share Price also appears in searches for SYMBIOTEC NSE and SYMBIOTEC BSE because the stock is being tracked as part of broader Stock Market Today and Share Market Today discussions. Univest presents the latest share price update, market capitalisation and sector context in one place so readers can follow the stock alongside other Stocks in News and 52 Week High Stocks.

Frequently Asked Questions

Why did SYMBIOTEC Share Price hit a fresh 52-week high?

Ans. The latest Univest data confirms the price event, with SYMBIOTEC Share Price touching Rs 1,193.90. The figures do not establish a company-specific catalyst, so the move should be read as a verified price event.

What is the current SYMBIOTEC Share Price today?

Ans. SYMBIOTEC Share Price was last traded at Rs 1,163.35, after rising 2.55% from the previous close of Rs 1,134.40. That places it near the day’s peak in early trade.

What is the market capitalisation of SYMBIOTEC?

Ans. SYMBIOTEC’s market capitalisation stood at Rs 7,030.58 crore. Market cap indicates company size, and in this case it places the stock within the same market-cap band as several listed pharmaceutical peers.

How expensive is SYMBIOTEC Share Price versus peers?

Ans. SYMBIOTEC’s P/E ratio is 66.32, above the same-industry median of 32.74 and average of 48.99. Its P/B of 4.91 is also above the industry median of 2.99. The stock moved 2.55% so far today.

What do the ROE and ROCE numbers show for SYMBIOTEC?

Ans. ROE is 11.22% and ROCE is 12.41%. Both are positive, but each sits below the same-industry medians of 11.87% and 13.88%, which gives a clear comparison point.

Does SYMBIOTEC pay a dividend?

Ans. The dividend yield is 0.00%. That means the current price does not carry a cash yield in the latest figures, so valuation and earnings metrics become more important in SYMBIOTEC Share Price analysis.

What are the key price levels for SYMBIOTEC Share Price today?

Ans. The stock opened at Rs 1,136.10, traded between Rs 1,115.00 and Rs 1,193.90, and last stood at Rs 1,163.35. The fresh 52-week high is Rs 1,193.90. The stock moved 2.55% so far today.

Where can I track SYMBIOTEC Share Price news?

Ans. Univest tracks SYMBIOTEC Share Price Today, market cap, valuation ratios and sector comparisons in one place. Readers can also follow SYMBIOTEC Stock News and SYMBIOTEC Latest News for ongoing updates.

Track SYMBIOTEC Share Price on Univest

Use SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

You can track SYMBIOTEC Share Price on Univest for live price updates, 52-week levels, valuation ratios, market capitalisation, sector comparison and broader stock analysis. Univest also helps readers follow SYMBIOTEC Share Price Today, SYMBIOTEC Share Price Live and SYMBIOTEC Latest News in one place.